GEROPHARM is one of the leaders in the field of biotechnology products in particular in development and production of recombinant human insulin and insulin analogues in Russia. The company is engaged in investing in technological development and setting up of a modern pharmaceutical infrastructure. Expertise lies mainly within the areas of endocrinology, neurology, psychiatry, ophthalmology, gynecology. The plant capacity of GEROPHARM, certified according to the international quality standards of GMP, is enough to cover 30 % of insulin demand of the Russian Federation. In the near future production facilities of GEROPHARM will fully cover needs of Russian patients and will allow to develop export opportunities. One of the priorities is development of insulin analogues, which is in line with the goal to strengthen the existing portfolio with advanced products. GEROPHARM is planning to introduce a full pipeline of insulin biosimilars.
| Website | http://www.geropharm.com |
| Revenue | $117.8 million |
| Employees | View employees |
| Address | 11b Degtyarniy Ln St, Saint Petersburg, St.-Petersburg 191144, RU |
| Phone | +7 812 703-79-75 |
| Fax | +7 495 995-09-17 |
| Technologies |
JavaScript
,
HTML
,
PHP
+19 more
(view full list)
|
| Industry | Manufacturing General, Manufacturing |
| Competitors | JSC BIOCAD, АО "Биннофарм, Sofia Municipality, Glenmark Pharmaceuticals, KK Krka, STADA APAC, AstraZeneca, Teva Pharmaceuticals, Novartis, GSK +29 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Geropharm Ltd employee's phone or email?
Geropharm Ltd Questions
The Geropharm Ltd annual revenue was $117.8 million in 2026.
Geropharm Ltd is based in Saint Petersburg, St.-Petersburg.
The NAICS codes for Geropharm Ltd are [3254, 325, 32541, 32].
The SIC codes for Geropharm Ltd are [28, 283, 2834].
